|
Archive 2001
Régime d'assurance-médicaments du Manitoba
Mises à jour des listes 2001
Posted December 20, 2001
Québec
Update to Edition 10 effective January 1, 2002
Highlights
New products, modifications
Posted December 18, 2001
Alberta
Notice - Effective December 16, 2001
Highlights
The Aricept Initial Prescription Program ends December 15, 2001
Posted December 18, 2001
Alberta
Quarterly Update - January 1, 2002
Highlights
Changes to the special authorization criteria
for coverage of alendronate and risedronate.
As well SA Criteria changes have been made to Eprex and Rilutek.
New Products Added: Comtan, Zyvoxam.
Deferred Product: Renagel.
Not Added: Diamicron MR and Nexium.
Posted December 17, 2001
Nova Scotia
December Bulletin effective December 15, 2001
Highlights
Correction: An error reported in October Bulletin - Flexitec 10mg Tab by Altimed is not discontinued, instead Alti-Cyclobenzaprine
10mg Tab by Altimed is discontinued. New interchangeable categories and changes to existing. Addition: Novo Test Strips.
Posted December 17, 2001
British Columbia
Changes to Benefit Plans effective January 1, 2002
Highlights
Pharmcare beneficiary cost sharing changes: Seniors with premium assistance,
will pay up to $10 per prescription to an annual maximum of $200.
The deductible will now include both drug costs and dispensing fees.
All other seniors will pay $25 for each prescription to a maximum of $275 per year.
As well Seniors with premium assistance will pay prescription drug costs to a maximum of $800 per year.
Individuals under 65 and their families will pay all prescription drug costs to maximum of $1,000 per year,
after which they pay 30% of total prescription costs to a ceiling of $2,000 per year.
Posted December 17, 2001
Nova Scotia
December Bulletin effective December 15, 2001
Highlights
Correction: An error reported
in October Bulletin - Flexitec 10mg Tab by Altimed is not discontinued, instead Alti-Cyclobenzaprine
10mg Tab by Altimed is discontinued. New interchangeable categories and changes to existing. Addition:
Novo Test Strips.
Posted December 10, 2001
Alberta
Addition to AHWDBL effective December 1, 2001
Highlights
Apo-Warfarin will be added and join existing interchangeable groups
Posted December 3, 2001
Nova Scotia
November Bulletin effective December 1, 2001
Highlights
New Exception Status: Estalis-Sequi,
Estradot, Singular; Change in Exception Status: Insulin Lispro, Not Listed: Ativan Sublingual;
New Listing: Atacand Plus, Desferrioxamine Mesilate, Hydromorph ontin, Lipitor, Micardis Plus, Rosasol,
Sandostatin LAR, Serc, Singulair, Accu-Chek Compact Test Strips, Sof-Tact Test Strips, etc.
Posted November 30, 2001
British Columbia
Reference Drug Program November 23, 2001
Highlights
A panel has been created to seek cost-effective alternatives to BC Pharmacare's reference drug-pricing program.
Posted November 30, 2001
British Columbia
Ministry of Health News - October 17, 2001
Highlights
Changes effective November 19, 2001 -
New: Riluzole, Delistings: Anabolic steroids, Flavoxate, Nasal corticosteroids, Vancomycin,
Topical antifungal skin preparations, Growth Hormones for Adults.
Posted November 16, 2001
New Brunswick
Product Update #43, Bulletin #528, November 9, 2001
Highlights
Interchangeable Product Additions/Generic Warfarin Fact Sheet
Posted November 13, 2001
Newfoundland
November 2001 Version
Posted November 12, 2001
British Columbia
Pharmacare Newsletter November 7, 2001
Highlights
New Benefits: Alti-Amoxi Clav, Pancrease,
Procytox, Lipitor, SERC, Apo-Trimethoprim; Non-Benefits: Apo-Loratadine, Apo-Midazolam inj.;
Limited Coverage Drugs: Micardis Plus, Atacand Plus, Novo-Terbinafine, Phentolamine Mesylate
AND Effective August 16, 2001 Baycol is no longer available as a benefit.
Posted November 6, 2001
Nova Scotia
October Bulletin effective November 1, 2001
Highlights
New Products added: Apo-Warfarin, Taro-Warfarin, Numerous Discontinued Products and Interchangeable Products
Posted October 19, 2001
British Columbia
Addendum to Pharmacare Newsletter effective November 19, 2001
Highlights
Nasocort and Nasocort AQ removed as benefits effective Nov 19, 2001
Posted October 18, 2001
British Columbia
Pharmacare Newsletter November 19, 2001
Highlights
Change in benefit status/coverage of several products including Flavoxate, Rilutek, Blood Glucose Strips, Topical anti-fungal preparations and oral Vancomycin.
Posted October 5, 2001
Alberta
Update (Correction) - October 2001
Highlights
Strength for Zyprexa Zydis (DIN 2243086) was incorrectly reported as 2.5mg in the October 2001 quarterly update. The correct strength is 5mg
Posted October 5, 2001
Alberta
Quarterly Update - October 1, 2001
Highlights
New Products Added: DDAVP, Remeron, Singulair, Teveten, Zyprexa Zydis;
Declined: Tamiflu and Xenical,
New Special Authorization: Peg-Intron, Rilutek;
Revised Special Authorization Criteria: Aggrenox, Plavix
Posted September 26, 2001
New Brunswick
Bulletin #525, effective September 14, 2001
Highlights
New special authorizations: Zyprexa-Zydis
(5 and 10mg), Oxy IR, OxyContin CR Seroquel (150mg), Sadvair Diskus, Tobi solution, Zomig Rapimelt (2.5mg);
Additions: Taro-Warfarin, Lipitor, Lipidil Supra, Kwellada-P Crème Rinse, Prograf AND a Clinical and Benefit
Status Summary of NSAIDs and COX-2 Inhibitors in the treatment of arthritis.
Posted September 25, 2001
Manitoba
Bulletin #33, effective September 24, 2001
Highlights
Baycoll delisted effective September 24, 2001, Additions: Seroquel, Mesylate, Alti-Doxazosin, Alti-Zopiclone, Zyprexa Zydis etc.
new Interchangeable categories, Product Deletions
Posted September 19, 2001
Nova Scotia
Pharmacists' Bulletin #01-10, effective October 1, 2001
Highlights
Drug Assistance for Cancer Patients, Baycol and Vioform HC Cream are delisted, and new products added.
Posted September 18, 2001
Ontario
ODB Update 2, Edition No 37 effective October 11, 2001
Highlights
Maximum price set for blood glucose test strips and nutrition products, Baycol delisted, 56 product additions etc.
Posted August 30, 2001
Alberta
Benefact Bulletin effective August 2001
Highlights
Baycoll delisted effective August 11, 2001, New Diabetes PINs
Posted August 22, 2001
British Columbia
Pharmacare Newsletter effective August 21, 2001
Highlights
New Listings:Thiamine HCI,Apo-Amoxi clav, Lorazepam vial; Special Authorization:Phoxal-ticlopidine, Mirapex, Mobicox, Zanaflex; No Listing: Amikacin sulfate injection, Amiken injection.
Posted August 21, 2001
Manitoba
Bulletin #32 effective August 20, 2001
Highlights
New Listings, Special Authorizations, Delistings
|
